“Leveraging our extensive M&A history and experience, we are actively integrating these facilities into our network, and will build on our legacy as a top-tier medical operator in preparation for potential adult use in Virginia. Additionally, expanding our Arizona operations allows us to further scale our retail footprint and broaden access to our award-winning brand portfolio with increased cultivation capacity and high-performing dispensaries in attractive locations in Prescott and Tempe. We are thankful for the Cannabist team’s partnership, and thrilled to welcome new colleagues in Virginia and Arizona as we turn the page on an exciting new chapter for Verano.” - George Archos, Verano CEO & Chairman Read more: https://bit.ly/4fOdQ3P
Verano’s Post
More Relevant Posts
-
Seeking New Leadership for Michigan Cannabis Events After several rewarding years, I'm shifting my focus to new ventures and looking for an enthusiastic leader to take over Michigan Cannabis Events. This is a great opportunity to steer a well-established brand in the cannabis industry. Included in the transition: ✅ Website ✅ Social Media Presence ✅ Original Logos Interested in exploring this opportunity? Connect with me directly here on LinkedIn or visit the website Let’s discuss how you can take this project to new heights! #MichiganCannabis #CannabisIndustry #CannabisBlog
To view or add a comment, sign in
-
-
Looking forward to being back for a second straight year at Business of Cannabis, especially now that New York has 194 adult-use dispensaries open across the State. 𝑾𝒊𝒍𝒍 𝒃𝒆 𝒊𝒏𝒕𝒆𝒓𝒆𝒔𝒕𝒆𝒅 𝒊𝒏 𝒆𝒙𝒑𝒍𝒐𝒓𝒊𝒏𝒈 𝒕𝒉𝒆 𝒇𝒐𝒍𝒍𝒐𝒘𝒊𝒏𝒈: 🌆 Latest on the competitive landscape, How Retail Dispensaries (The Travel Agency: A Cannabis Store, Gotham, Housing Works, Dazed Cannabis, CONBUD NY, Happy Munkey LLC, The Flowery, Silver Therapeutics, etc) are doing vs. MSOs/ROs (Registered Organizations) 💻 Tech Stack for operators (who's winning market share) 🏪 Upcoming dispensary openings 🍬 NY-based brands (Airo Brands, Dank By Definition, ayrloom, Edie Parker, House of Puff Inc., Naturae ) vs. multi-state brands (1906, Aster, Cookies, Fernway, Grön, Heavy Hitters, Jetty Extracts, Kiva Brands, Inc., LEVEL, Old Pal, Rove Brand, Wana Brands, Wyld) 💲 $75.8M in August 2024 Sales: Flower ($26.5M), Vape ($20.4M), Pre-Roll ($14.5M), Edible ($9.7M) (https://lnkd.in/ejTkxqvS) 💰 Latest on VC-backed NY-based companies (Lucid Green, Flyers Cocktail Company, Frontier Risk, Surfside, Prelude) 🔬 Lab Testing (ACT LAB, Kaycha Labs, Certified Testing & Data, Green Analytics, LLC) since we haven't seen the same negative headlines as in other states, though it is early days 🍷 I typically try to organize smaller gatherings around conferences, so if there's interest in attending/co-hosting (likely will be for Monday, 11/11), let me know https://lnkd.in/eb83vZXk
Speaker announcement 🗣 Dai Truong joined Arlington Capital Advisors in 2021 and is focused on growing the firm’s cannabis practice. Prior to joining Arlington, Dai served as VP Corporate Development for Left Coast Ventures, a diversified cannabis and hemp company specializing in cultivation, manufacturing, brand development and distribution. Dai has held various corporate development and investment positions at MedMen, Anheuser-Busch InBev, Austin Ventures and Bank of America Merrill Lynch. Dai graduated from the University of California, Los Angeles (UCLA). Looking forward to Dai's insights on November 12. 🎫 👉https://lnkd.in/gMZz899y
To view or add a comment, sign in
-
-
We've got some M&A news to share today! 🙌 Trulieve has settled its ongoing litigation with Harvest of Ohio. Trulieve receives operational dispensaries in Columbus and Beavercreek, as well as a "service agreement" on the Level 1 Cultivation and Processing facility, which I interpret to mean they are acquiring those assets as well bringing its total Ohio footprint to 3 operational dispensaries (2 in Columbus and 1 in Beavercreek) to go along with a Level 1 Grow and Processor. Harvest of OH founder Ariane Kirkpatrick keeps her operational dispensary in Athens Ohio and presumably one or more additional retail licenses as awarded by the state next month, which shall be rebranded Mavuno. Congrats to both parties for getting this thing across the finish line. Not a bad outcome to litigation for both parties in my view, especially in a market like Ohio that is slated to begin adult-use sales as early as the 2nd or 3rd week of June. Additional details of the transaction were not disclosed. FYI - the cap for retail dispensaries in Ohio is 8, meaning both parties have an opportunity to add additional stores to their footprints in the future. I for one am stoked to see transactions like this happening in the market and am excited for the start of Rec sales in Ohio which are expected to hit $1.5 to $2 BILLION in the first year. WOW. 😳 #cannabisindustry #breakingnews #capitalmarkets https://lnkd.in/gt2TF9cF
Trulieve Announces Litigation Settlement and Acquisition of Ohio Assets
prnewswire.com
To view or add a comment, sign in
-
A few months ago, a friend asked me why I hadn't considered becoming a board member given my broad experience in pharmaceutical product and portfolio strategy. Intrigued, I decided to educate myself on boards to potentially make a positive impact in the future. Recently, I attended a compelling lecture on Board Governance by #Cornelia #Ritz #Bossicard at the #Boardroom. Here are some key takeaways that resonated with me: ✅ Join a board for the right reasons, not money—average payment for a NED in Switzerland is 22k CHF, along with potential risks. ✅ Prioritize due diligence before accepting a board role. ✅ Ensure alignment between the board's needs, company strategy, values, your skills, and personalities. ✍ Do you have other learnings to share? ☀ Excited to continue learning alongside my exceptional colleagues at the Boardroom, who inspire me with each interaction!
To view or add a comment, sign in
-
We are proud to introduce Michael Jay Le, our dynamic Chief Operations Officer, who is integral to Cannagen’s success. Michael’s expertise in operations management and facility design ensures that our projects not only meet but exceed industry standards. Michael’s role at Cannagen involves: • Facility Design & Construction: Leading the development of cutting-edge cannabis cultivation and production facilities, ensuring they are efficient, compliant, and state-of-the-art. • Operational Management: Streamlining operations across the board to maximize efficiency and maintain the highest quality standards. • Sustainability Initiatives: Implementing sustainable practices in facility management to promote long-term environmental health. Michael’s dedication to excellence in operations and facility design is at the core of Cannagen’s mission to revolutionize Thailand’s medical cannabis industry. His leadership and vision are pivotal in driving our success and ensuring the highest standards in every project we undertake. Join us in celebrating Michael Jay Le’s incredible contributions and the innovative future he is building for Cannagen and the broader medical cannabis community! #Cannagen #CannabisIndustry #OperationsManagement #FacilityDesign #Leadership #Sustainability
To view or add a comment, sign in
-
-
🌟 Reflecting on a Year of Industry Insights! 🚀 It's a joy to celebrate the success of our engaging video discussions exploring the intricacies of the pharmaceutical and cannabis sectors. 💼🌿 A heartfelt thank you to all who have been a part of this journey – your passion and expertise have been the driving force behind the success of these discussions. 🙏 These virtual gatherings have been a testament to the power of collaborative learning and shared insights. Our diverse panel of experts brought forth a mosaic of perspectives, delving into the nuances that define the ever-evolving landscapes of pharmaceuticals and cannabis. From regulatory landscapes to groundbreaking innovations, our discussions have been a melting pot of ideas and experiences. The active participation and enthusiasm from all contributors have not only fueled these conversations but have also underscored the richness of our industry knowledge. Together, we navigated through the challenges, celebrated successes, and embraced the dynamic nature of our fields. 🎉💊 Your commitment to staying informed and engaged has not only enhanced our collective understanding but has also solidified our position as influencers in these industries. Moving forward, let's carry forward this spirit of exploration, collaboration, and shared growth. Here's to another year of pushing boundaries, fostering innovation, and making impactful strides in the pharmaceutical and cannabis realms! 🌐✨ #IndustryDialogue #PharmaCannInsights #YearInReview #CollaborativeLearning #InnovationJourney #Gratitude #NextChapter 🥂 Dan Berman Marshall Ogen Rica Askew Beth Holt Kim Christmas Erika Sinner Bernadette Tosti Sonja Foster-Storch Rahul Mahadevan Lori Abrams Kieve Huffman leah heise Alexandra Ruby Rebecca Abraham RN, BSN George Jage Wendy Campbell Jon Nelson Stacey Udell Matha Figaro
Industry Insights: A Year in Reflection
To view or add a comment, sign in
-
During my undergraduate studies, I aimed to work in the biotech 💉 industry. Since pivoting into the legal ⚖ practice, I'm all-the-more happy to have landed at Fenwick & West, which has a dual-focus on both the general tech sector and the life sciences sector. This duality has shaped my own patent prosecution practice with a core focus on the overlap of machine-learning techniques as applied to biotech research & development. 🏆 🎉 #LifeSciences #Healthtech #PGOTY
In recognition of Fenwick’s remarkable life sciences impact, Law360 named us among its life sciences Practice Groups of the Year for 2023. Raising hundreds of millions in capital, guiding pivotal industry collaborations, protecting groundbreaking IP, and breathing life into a sluggish year for M&A with blockbuster deals including DICE Therapeutics’ $2.4 billion acquisition by Eli Lilly and Company and Chinook Therapeutics’ $3.5 billion sale to Novartis—all of it resonated through the legal industry. From inception to market leaders, Fenwick assists life sciences companies at every stage of their lifecycle with a broad array of services and a holistic approach that supports growth. Learn more: https://bit.ly/3vIOLEK #LifeSciences #Innovation #Awards
To view or add a comment, sign in
-
📣 Did you know the Isle of Man Medicinal Cannabis Licence allows export of product out of the UK to Europe and further a field; and not just supply a domestic market ? ? 📣 We do and we can help you do this and obtain the best opportunities and customers for your business. Want to discuss the Medical Cannabis licensing options in the Isle of Man and Malta get in touch for a chat 🇮🇲 🇲🇹 🔹 Cultivation; 🔹 Manufacture; 🔹 Import / Export; 🔹 Wholesale Dealer Licenses. 🟢 Licensing process. 🟢 Jurisdiction requirements. 🟢 Import/Export Permits. 🟢 Advice on building security requirements. 🟢 Sector contacts. 🔆 We are here to help you with our subject matter experts and regulatory background 🔆
📅 Less than 2 weeks to Cannabis Europa 2024! 📅 Join us at The Barbican in London from 25-26 June 2024 for the leading event in the European cannabis industry. With over 1,500 influential leaders, investors, and key politicians, it's not to be missed. 🌱 Planning to attend? Let's connect. Meet our team at Stand GF14. - Kristy Maxwell (nee Purvis), Associate Director - Koko Dlamini, Business Development Manager #AffinityGroup #CannabisEuropa #Cannabis #London
To view or add a comment, sign in
-
-
Very nice piece summarising a talk on key elements to consider when building efficient regulatory documents
💡Shining a Spotlight on Tanja Jensen & Matilde Thye Kveiborg 💡 Tanja & Matilde, of AIXIAL GROUP, delivered a keynote presentation at last week's COG Nordics meeting in Copenhagen. Discussing the importance of efficient #medicalwriting to accelerate #drugdevelopment Missed it? Sharing a presentation overview with key takeaways below! Join our next European meeting in Amsterdam this November, full details here: https://lnkd.in/eu2aWRfn
COG Nordics 2024 - Accelerating Drug Development Through Efficient Regulatory Documents
thepbcgroup.com
To view or add a comment, sign in
-
@Catailyst, Inc. Trending Topics: Sangamo Therapeutics, Inc. Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in #Fabry Disease With BLA Submission Expected in 2025 https://lnkd.in/d-HxtncX FDA confirms that estimated glomerular filtration rate (eGFR) slope data at one year across all Phase 1/2 patients can serve as primary basis for approval under Accelerated Approval pathway #Timeline Data supporting Accelerated Approval pathway available in first half of 2025 BLA submission expected in the second half of 2025. #Healthcare #FDA #Biotechnology #Fabry
Catailyst
catailyst.ai
To view or add a comment, sign in